Evidence map›Paper›PMID 28830374›Full record

ArticleBMC cancer2017

EMX2 gene expression predicts liver metastasis and survival in colorectal cancer.

Berk Aykut, Markus Ochs, Praveen Radhakrishnan, Adrian Brill, Hermine Höcker, Sandra Schwarz, Daniel Weissinger, Roland Kehm, Yakup Kulu, Alexis Ulrich and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. CRISPR/dCas9-Mediated DNA Methylation Editing onInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Berk AykutDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Markus OchsDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Praveen RadhakrishnanDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Adrian BrillDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Hermine HöckerDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Sandra SchwarzDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Daniel WeissingerDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Roland KehmDepartment of Biotechnology, University of Heidelberg, Heidelberg, Germany.
Yakup KuluDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Alexis UlrichDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Martin SchneiderDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. m.schneider@uni-heidelberg.de.
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Empty Spiracles Homeobox (EMX-) 2 gene has been associated with regulation of growth and differentiation in neuronal development. While recent studies provide evidence that EMX2 regulates tumorigenesis of various solid tumors, its role in colorectal cancer remains unknown. We aimed to assess the prognostic significance of EMX2 expression in stage III colorectal adenocarcinoma.

methodsExpression levels of EMX2 in human colorectal cancer and adjacent mucosa were assessed by qRT-PCR technology, and results were correlated with clinical and survival data. siRNA-mediated knockdown and adenoviral delivery-mediated overexpression of EMX2 were performed in order to investigate its effects on the migration of colorectal cancer cells in vitro.

resultsCompared to corresponding healthy mucosa, colorectal tumor samples had decreased EMX2 expression levels. Furthermore, EMX2 down-regulation in colorectal cancer tissue was associated with distant metastasis (M1) and impaired overall patient survival. In vitro knockdown of EMX2 resulted in increased tumor cell migration. Conversely, overexpression of EMX2 led to an inhibition of tumor cell migration.

conclusionsEMX2 is frequently down-regulated in human colorectal cancer, and down-regulation of EMX2 is a prognostic marker for disease-free and overall survival. EMX2 might thus represent a promising therapeutic target in colorectal cancer.

Indexed as

Biomarkers, TumorGene ExpressionAdenoviridaeCell Line, TumorCell MovementCohort StudiesColorectal NeoplasmsEmpty Spiracles Homeobox ProteinsFemaleFollow-Up StudiesGenetic VectorsGene Transfer TechniquesHomeodomain ProteinsHumansLiver NeoplasmsMaleBiomarkers, TumorEmpty Spiracles Homeobox ProteinsHomeodomain ProteinsTranscription FactorsAdenoviral therapyColorectal cancerHomeobox geneMetastasisUnivariate analyses

Identifiers

PMID28830374
PMCPMC5568393
OpenAlexW2745920200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.